Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.3.5.5 (
CPS
)
1,262
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The urea-synthesizing enzymes of human liver tissues, namely, carbamylphosphate synthetase (
CPS
, EC 2.7.2.2), ornithine transcarbamylase (OTC, EC 2.1.3.3), arginine synthetase system, argininosuccinase (
ASase
, EC 4.3.2.1), and arginase (EC 3.5.3.1) were measured between pre- and postnatal periods. Specimens from 67 autopsied human livers obtained from fetuses, premature infants, newborn infants, infants, children, and adults were examined. The mean activities of the enzymes showed an increased pattern for OTC and arginase at fetal life, whereas those of
CPS
, arginine synthetase system, and
ASase
of fetal livers showed no significant difference in each stage. Except for arginase, the other four enzyme activities were higher in the postnatal period than those in the fetal life. Arginase activities indicated maximal increase at a gestational age between 28 and 31 weeks and decreased in the postnatal life.
...
PMID:A study of urea-synthesizing enzymes in prenatal and postnatal human liver. 738 44